USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Comparing iShares US Pharmaceuticals ETF and iShares Biotech ETF

The Motley Fool +1 · ·by G4L

IBB
IBB iShares Biotechnology ETF
$212.50 -0.44%
View chart & analysis →
IHE IHE +0.71%
  1. 1The iShares US Pharmaceuticals ETF focuses on 53 holdings and has an expense ratio of 0.37%.
  2. 2The iShares Biotech ETF provides broad exposure to 243 companies and has an expense ratio of 0.44%.
  3. 3The iShares US Pharmaceuticals ETF has achieved a total return of 79% since 2021.

So what's the key point?

This compares the composition and costs of two types of US pharmaceutical products. The iShares US Pharmaceuticals ETF has generated a 79% return since 2021.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Biotech Innovation Cycle and Technological Advancement CNBC · Oct 25Comparing Fidelity MSCI Health Care Index ETF and iShares Biotechnology ETF The Motley Fool +1 · Oct 14Moderna, Merck melanoma vaccine succeeds in Phase 3; shares surge up to 83% Barrons.com +17 · Aug 19
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news